Cargando…
FOCUSED ECHOCARDIOGRAPHY FOR REDEFINING THE PROGNOSIS OF PATIENTS HOSPITALIZED WITH COVID-19 BEYOND CLINICAL DATA - DATA FROM THE PROVAR-COVID STUDY
Autores principales: | Nascimento, Bruno Ramos, Pimentel, Sander Luis G., Oliveira, Kaciane K.B., Franco, Juliane, Fraga, Clara L., Macedo, Frederico V.B., Rocha, Rodrigo T.L., Ávila, Renata Eliane, Barbosa, Marcia, Sable, Craig, Santos, Luiza P.A., Oliveira, Renan M., Ribeiro, Antonio, Beaton, Andrea, Nunes, Maria Carmo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091374/ https://www.ncbi.nlm.nih.gov/pubmed/34140113 http://dx.doi.org/10.1016/S0735-1097(21)04493-4 |
Ejemplares similares
-
Bedside echocardiography to predict mortality of COVID-19 patients beyond clinical data: Data from the PROVAR-COVID study
por: Pimentel, Sander Luis Gomes, et al.
Publicado: (2021) -
Investigation of the Familial Risk of Rheumatic Heart Disease with Systematic Echocardiographic Screening: Data from the PROVAR+ Family Study †
por: Franco, Juliane, et al.
Publicado: (2022) -
Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil
por: Ubels, Jasper, et al.
Publicado: (2020) -
Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study
por: Nascimento, Bruno R., et al.
Publicado: (2018) -
Challenges for the Implementation of the First Large-Scale Rheumatic
Heart Disease Screening Program in Brazil: The PROVAR Study
Experience
por: dos Santos, Julia Pereira Afonso, et al.
Publicado: (2017)